1. Home
  2. WVE vs OI Comparison

WVE vs OI Comparison

Compare WVE & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo O-I Glass Inc.

OI

O-I Glass Inc.

N/A

Current Price

$10.95

Market Cap

2.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
OI
Founded
2012
1903
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
WVE
OI
Price
$13.35
$10.95
Analyst Decision
Strong Buy
Buy
Analyst Count
15
7
Target Price
$31.47
$17.57
AVG Volume (30 Days)
2.2M
2.1M
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
$6,426,000,000.00
Revenue This Year
N/A
$3.07
Revenue Next Year
$119.93
$1.83
P/E Ratio
N/A
N/A
Revenue Growth
149.43
N/A
52 Week Low
$5.28
$9.23
52 Week High
$21.73
$16.91

Technical Indicators

Market Signals
Indicator
WVE
OI
Relative Strength Index (RSI) 47.54 24.24
Support Level $12.53 N/A
Resistance Level $14.56 $13.54
Average True Range (ATR) 0.79 0.63
MACD 0.01 -0.24
Stochastic Oscillator 23.84 3.87

Price Performance

Historical Comparison
WVE
OI

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: